Zai Lab Limited Share Price Deutsche Boerse AG
Stocks
1ZL
US98887Q1040
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.40 EUR | +4.19% |
|
+6.75% | +19.18% |
| 30/06 | Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing | MT |
| 16/06 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
| Market Cap | 230.22Cr 201.37Cr 185.74Cr 171.55Cr 325.51Cr 22TCr 330.98Cr 2.22TCr 871.5Cr 11TCr 864.39Cr 845.58Cr 37TCr | P/E 2026 * |
-9.25x | P/E 2027 * | -11x |
|---|---|---|---|---|---|
| Enterprise Value | 185.9Cr 162.61Cr 149.99Cr 138.53Cr 262.85Cr 18TCr 267.27Cr 1.79TCr 703.75Cr 8.73TCr 698.01Cr 682.82Cr 30TCr | EV / Sales 2026 * |
4.14x | EV / Sales 2027 * | 3.22x |
| Free-Float |
95.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Zai Lab Limited
| 1 day | +4.19% | ||
| 1 week | +6.75% | ||
| Current month | +10.13% | ||
| 1 month | +22.54% | ||
| 3 months | +0.58% | ||
| 6 months | +12.26% | ||
| Current year | +19.18% |
| 1 week | 16.2 |  | 17.4 |
| 1 month | 14.6 | | 17.4 |
| Current year | 13.2 | | 21 |
| 1 year | 13.2 | | 34.2 |
| 3 years | 12.4 | | 38.2 |
| 5 years | 12.4 | | 146 |
| 10 years | 12.4 | | 162 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ying Du
CEO | Chief Executive Officer | 61 | 01/04/2014 |
Ya jing Chen
DFI | Director of Finance/CFO | 58 | 07/07/2023 |
Rafael Amado
PSD | President | 62 | 01/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Du
CHM | Chairman | 61 | 01/04/2014 |
John Diekman
BRD | Director/Board Member | 83 | 01/01/2017 |
Peter Wirth
BRD | Director/Board Member | 75 | 01/01/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.19% | +6.75% | - | - | 230.22Cr | |
| -0.51% | +1.57% | +17.05% | -7.30% | 6.76TCr | |
| -5.16% | -8.63% | +38.70% | +203.59% | 5.16TCr | |
| +5.28% | +39.50% | +39.50% | +39.50% | 4.3TCr | |
| -2.10% | +0.89% | -48.99% | -53.63% | 4.09TCr | |
| +0.12% | -7.85% | +48.39% | -28.83% | 2.94TCr | |
| -10.83% | -14.41% | +102.94% | -44.10% | 2.71TCr | |
| -1.53% | -0.13% | +70.16% | +85.73% | 2.33TCr | |
| +3.88% | +2.16% | +11.36% | +192.66% | 1.99TCr | |
| -1.59% | -1.63% | +64.87% | +130.98% | 1.69TCr | |
| Average | -0.82% | -3.02% | +38.22% | +57.62% | 3.55TCr | |
| Weighted average by Cap. | -1.32% | -2.83% | +31.31% | +48.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45Cr 39Cr 36Cr 33Cr 63Cr 4.28TCr 65Cr 432.53Cr 169.86Cr 2.11TCr 168.47Cr 164.81Cr 7.25TCr | 60Cr 52Cr 48Cr 44Cr 84Cr 5.68TCr 86Cr 574.13Cr 225.46Cr 2.8TCr 223.62Cr 218.75Cr 9.62TCr |
| Net income | -24Cr -21Cr -19Cr -18Cr -34Cr -2.3TCr -35Cr -232.22Cr -91Cr -1.13TCr -90Cr -88Cr -3.89TCr | -16Cr -14Cr -13Cr -12Cr -22Cr -1.49TCr -22Cr -150.84Cr -59Cr -735.16Cr -59Cr -57Cr -2.53TCr |
| Net Debt | -44Cr -39Cr -36Cr -33Cr -63Cr -4.23TCr -64Cr -427.17Cr -167.75Cr -2.08TCr -166.38Cr -162.76Cr -7.16TCr | -39Cr -34Cr -31Cr -29Cr -55Cr -3.69TCr -56Cr -373.25Cr -146.58Cr -1.82TCr -145.38Cr -142.22Cr -6.25TCr |
| Date | Price | Change |
|---|---|---|
| 10/26/10 | €17.40 | +4.19% |
| 09/26/09 | €16.70 | +2.45% |
| 08/26/08 | €16.30 | +0.62% |
| 07/26/07 | €16.20 | 0.00% |
| 06/26/06 | €16.20 | -0.61% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZLAB Stock
- 1ZL Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
